BioRestorative Therapies, Inc. (BRTX)
收市後：
| 前收市價 | 1.4500 |
| 開市 | 1.4000 |
| 買盤 | 1.3400 x 100 |
| 賣出價 | 1.3900 x 100 |
| 今日波幅 | 1.3600 - 1.4300 |
| 52 週波幅 | 1.2000 - 7.1300 |
| 成交量 | |
| 平均成交量 | 950,751 |
| 市值 | 9.241M |
| Beta 值 (5 年，每月) | 61.68 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -3.4200 |
| 業績公佈日 | 2024年5月14日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 10.50 |
Insider Monkey10 Micro-Cap Healthcare Stocks Insiders Are Buying
In this article, we will take a detailed look at the 10 Micro-Cap Healthcare Stocks Insiders Are Buying. For a quick overview of such stocks, read our article 5 Micro-Cap Healthcare Stocks Insiders Are Buying. Investors have always been interested in the connection between insider buying and stock returns. Over the past several years there’s been a huge influx […]
Insider Monkey11 Most Volatile Stocks Under $5 For Day Trading
In this piece, we will take a look at the 11 most volatile stocks under $5 for day trading. If you want to skip our introduction to stock indicators and the broader market environment, then take a look at 5 Most Volatile Stocks Under $5 For Day Trading. While all stocks can be bought on […]
BenzingaEXCLUSIVE: Stem Cell Focused BioRestorative Ventures Into $63B Aesthetics Market Via Supply Agreement With Evolutionary Biologics
BioRestorative Therapies Inc (NASDAQ: BRTX) has entered into a supply agreement with Evolutionary Biologics, a supplier of biologic-based cosmetics. Under the supply agreement, BioRestorative, using its cGMP ISO-7 certified clean room, will manufacture tissue-based biologics for Evolutionary Biologics for cosmetic and aesthetic applications. The initial order of 5,000 vials represents a controlled launch and is expected to have a positive financial impact. The first-generation product formulated
